Anticoagulant Reversal Drugs
SKU
MRR-035DA3C636BB
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 646.38 million
2030
USD 1,457.59 million
2024
USD 725.40 million
CAGR
12.31%
Anticoagulant Reversal Drugs Market by Product (Andexxa, Idarucizumab, Protamine), Distribution (Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030

[199 Pages Report] The Anticoagulant Reversal Drugs Market size was estimated at USD 646.38 million in 2023 and expected to reach USD 725.40 million in 2024, at a CAGR 12.31% to reach USD 1,457.59 million by 2030.

Anticoagulant Reversal Drugs Market
To learn more about this report, request a free sample copy
Anticoagulant Reversal Drugs Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anticoagulant Reversal Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anticoagulant Reversal Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anticoagulant Reversal Drugs Market, highlighting leading vendors and their innovative profiles. These include Alexion Pharmaceuticals Inc., AMAG Pharmaceuticals, Inc., Amneal Pharmaceuticals, Inc., AstraZeneca PLC, Bausch Health Companies, Inc., BioVascular Inc., Boehringer Ingelheim GmbH, Cadila Healthcare Limited, CSL Limited, Daiichi Sankyo Company, Limited, Dr Reddy’s Laboratories Ltd,, Eli Lilly and Company, Fresenius Kabi AG, Genentech, Inc., Hikma Pharmaceuticals PLC, Octapharma AG, Otsuka Pharmaceutical Co., Ltd., and Pfizer, Inc..

Market Segmentation & Coverage

This research report categorizes the Anticoagulant Reversal Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Andexxa
    • Idarucizumab
    • Protamine
    • Tranexamic Acid
    • Vitamin K
  • Distribution
    • Hospital Pharmacies
    • Retail Pharmacies

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Anticoagulant Reversal Drugs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anticoagulant Reversal Drugs Market?
  3. What are the technology trends and regulatory frameworks in the Anticoagulant Reversal Drugs Market?
  4. What is the market share of the leading vendors in the Anticoagulant Reversal Drugs Market?
  5. Which modes and strategic moves are suitable for entering the Anticoagulant Reversal Drugs Market?

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & CoverageANTICOAGULANT REVERSAL DRUGS MARKET SEGMENTATION & COVERAGE
    3. Years Considered for the Study
    4. Currency & PricingUNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    5. Language
    6. Limitations
    7. Assumptions
    8. Stakeholders
  2. Research Methodology
    1. ANTICOAGULANT REVERSAL DRUGS MARKET RESEARCH PROCESS
    2. Define: Research Objective
    3. Determine: Research Design
    4. Prepare: Research Instrument
    5. Collect: Data Source
    6. Analyze: Data Interpretation
    7. Formulate: Data Verification
    8. Publish: Research Report
    9. Repeat: Report Update
  3. Executive Summary
    1. ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, 2023 VS 2030
  4. Market Overview
    1. IntroductionANTICOAGULANT REVERSAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
    2. Anticoagulant Reversal Drugs Market, by RegionANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  5. Market Insights
    1. Market DynamicsANTICOAGULANT REVERSAL DRUGS MARKET DYNAMICS
      1. Drivers
        1. Increasing prevalence of bleeding disorders and anticoagulant therapies
        2. Growing number of product approvals worldwide
        3. Increasing incidence of unplanned surgeries
      2. Restraints
        1. High cost of the patent drugs
      3. Opportunities
        1. Improvements in reimbursement policies globally
        2. Ongoing research activities and funding to treat anticoagulant-related bleeds
      4. Challenges
        1. Stringent regulatory reforms due to severe risks associated with the reversal of anticoagulation
    2. Market Segmentation Analysis
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Anticoagulant Reversal Drugs Market, by Product
    1. IntroductionANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
    2. AndexxaANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY ANDEXXA, BY , 2018-2030 (USD MILLION)
    3. IdarucizumabANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY IDARUCIZUMAB, BY , 2018-2030 (USD MILLION)
    4. ProtamineANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PROTAMINE, BY , 2018-2030 (USD MILLION)
    5. Tranexamic AcidANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY TRANEXAMIC ACID, BY , 2018-2030 (USD MILLION)
    6. Vitamin KANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY VITAMIN K, BY , 2018-2030 (USD MILLION)
  7. Anticoagulant Reversal Drugs Market, by Distribution
    1. IntroductionANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    2. Hospital PharmaciesANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY , 2018-2030 (USD MILLION)
    3. Retail PharmaciesANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY , 2018-2030 (USD MILLION)
  8. Americas Anticoagulant Reversal Drugs Market
    1. Introduction
    2. AMERICAS ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)AMERICAS ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    3. AMERICAS ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)AMERICAS ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)AMERICAS ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Argentina
    5. ARGENTINA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)ARGENTINA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    6. Brazil
    7. BRAZIL ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)BRAZIL ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    8. Canada
    9. CANADA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)CANADA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    10. Mexico
    11. MEXICO ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)MEXICO ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    12. United States
    13. UNITED STATES ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)UNITED STATES ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    14. UNITED STATES ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)UNITED STATES ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)UNITED STATES ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  9. Asia-Pacific Anticoagulant Reversal Drugs Market
    1. Introduction
    2. ASIA-PACIFIC ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)ASIA-PACIFIC ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    3. ASIA-PACIFIC ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)ASIA-PACIFIC ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)ASIA-PACIFIC ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Australia
    5. AUSTRALIA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)AUSTRALIA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    6. China
    7. CHINA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)CHINA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    8. India
    9. INDIA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)INDIA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    10. Indonesia
    11. INDONESIA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)INDONESIA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    12. Japan
    13. JAPAN ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)JAPAN ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    14. Malaysia
    15. MALAYSIA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)MALAYSIA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    16. Philippines
    17. PHILIPPINES ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)PHILIPPINES ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    18. Singapore
    19. SINGAPORE ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SINGAPORE ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    20. South Korea
    21. SOUTH KOREA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SOUTH KOREA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    22. Taiwan
    23. TAIWAN ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)TAIWAN ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    24. Thailand
    25. THAILAND ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)THAILAND ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    26. Vietnam
    27. VIETNAM ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)VIETNAM ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  10. Europe, Middle East & Africa Anticoagulant Reversal Drugs Market
    1. Introduction
    2. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    3. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Denmark
    5. DENMARK ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)DENMARK ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    6. Egypt
    7. EGYPT ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)EGYPT ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    8. Finland
    9. FINLAND ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)FINLAND ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    10. France
    11. FRANCE ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)FRANCE ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    12. Germany
    13. GERMANY ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)GERMANY ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    14. Israel
    15. ISRAEL ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)ISRAEL ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    16. Italy
    17. ITALY ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)ITALY ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    18. Netherlands
    19. NETHERLANDS ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)NETHERLANDS ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    20. Nigeria
    21. NIGERIA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)NIGERIA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    22. Norway
    23. NORWAY ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)NORWAY ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    24. Poland
    25. POLAND ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)POLAND ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    26. Qatar
    27. QATAR ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)QATAR ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    28. Russia
    29. RUSSIA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)RUSSIA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    30. Saudi Arabia
    31. SAUDI ARABIA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SAUDI ARABIA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    32. South Africa
    33. SOUTH AFRICA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SOUTH AFRICA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    34. Spain
    35. SPAIN ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SPAIN ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    36. Sweden
    37. SWEDEN ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SWEDEN ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    38. Switzerland
    39. SWITZERLAND ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SWITZERLAND ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    40. Turkey
    41. TURKEY ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)TURKEY ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    42. United Arab Emirates
    43. UNITED ARAB EMIRATES ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
    44. United Kingdom
    45. UNITED KINGDOM ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)UNITED KINGDOM ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  11. Competitive Landscape
    1. FPNV Positioning MatrixANTICOAGULANT REVERSAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023ANTICOAGULANT REVERSAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
    2. Market Share Analysis, By Key PlayerANTICOAGULANT REVERSAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023ANTICOAGULANT REVERSAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
    3. Competitive Scenario Analysis, By Key Player
  12. Competitive Portfolio
    1. Key Company Profiles
      1. Alexion Pharmaceuticals Inc.
      2. AMAG Pharmaceuticals, Inc.
      3. Amneal Pharmaceuticals, Inc.
      4. AstraZeneca PLC
      5. Bausch Health Companies, Inc.
      6. BioVascular Inc.
      7. Boehringer Ingelheim GmbH
      8. Cadila Healthcare Limited
      9. CSL Limited
      10. Daiichi Sankyo Company, Limited
      11. Dr Reddy’s Laboratories Ltd,
      12. Eli Lilly and Company
      13. Fresenius Kabi AG
      14. Genentech, Inc.
      15. Hikma Pharmaceuticals PLC
      16. Octapharma AG
      17. Otsuka Pharmaceutical Co., Ltd.
      18. Pfizer, Inc.
    2. Key Product Portfolio
  1. Alexion Pharmaceuticals Inc.
  2. AMAG Pharmaceuticals, Inc.
  3. Amneal Pharmaceuticals, Inc.
  4. AstraZeneca PLC
  5. Bausch Health Companies, Inc.
  6. BioVascular Inc.
  7. Boehringer Ingelheim GmbH
  8. Cadila Healthcare Limited
  9. CSL Limited
  10. Daiichi Sankyo Company, Limited
  11. Dr Reddy’s Laboratories Ltd,
  12. Eli Lilly and Company
  13. Fresenius Kabi AG
  14. Genentech, Inc.
  15. Hikma Pharmaceuticals PLC
  16. Octapharma AG
  17. Otsuka Pharmaceutical Co., Ltd.
  18. Pfizer, Inc.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Anticoagulant Reversal Drugs Market
The Global Anticoagulant Reversal Drugs Market size was estimated at USD 646.38 million in 2023 and expected to reach USD 725.40 million in 2024.
The Global Anticoagulant Reversal Drugs Market to grow USD 1,457.59 million by 2030, at a CAGR of 12.31%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.